← Leaderboards
Mark Franklin Newman
Duke University
$5,270,323
Attributed
$5,270,323
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $651.1K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$5,270,323 · 7
By mechanism
R01$5,117,216 · 4
M01$153,107 · 3
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Jeffrey None Crawford$10,066,024
- Miles Berger$6,972,812
- Doris A Taylor$6,306,380
- Debra A. Schwinn$11,466,054
- Laura E Niklason$22,016,504
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchCognition DisordersPostoperative ComplicationsNeuropsychological TestsAgingClinical TrialsApolipoprotein ENeuroprotectantsQuality Of LifeHuman Therapy EvaluationHuman Old Age (65+)Postoperative StateCoronary BypassGenotypeHeart /Lung BypassCognitionInflammationAnesthesiaHuman Middle Age (35-64)Human Genetic Material TagGenetic SusceptibilityCardiovascular SurgeryMagnesium Deficiency
Grant awards (19)
PeriOperative Interventional Neuroprotection Trial-POINT$377,720
R01 · FY2006 · HL · contact PI
PeriOperative Interventional Neuroprotection Trial-POINT$571,974
R01 · FY2005 · HL
PERI-OPERATIVE INTERVENTIONAL NEUROPROTECTION TRIAL (POINT)$79,083
M01 · FY2005 · RR
PeriOperative Interventional Neuroprotection Trial-POINT$562,346
R01 · FY2004 · HL
Peri-Operative Interventional Neuroprotection Trial$37,424
M01 · FY2004 · RR
Neuroprotection with Lidocaine During Cardiac Surgery$36,600
M01 · FY2004 · RR
PeriOperative Interventional Neuroprotection Trial-POINT$553,104
R01 · FY2003 · HL
GENETICS, INFLAMMATION &POST-OP COGNITIVE DYSFUNCTION$330,675
R01 · FY2003 · AG
AGING AND COGNITION AFTER CARDIAC SURGERY$283,431
R01 · FY2003 · AG
PeriOperative Interventional Neuroprotection Trial-POINT$552,597
R01 · FY2002 · HL
GENETICS, INFLAMMATION &POST-OP COGNITIVE DYSFUNCTION$437,876
R01 · FY2002 · AG
AGING AND COGNITION AFTER CARDIAC SURGERY$354,850
R01 · FY2002 · AG
GENETICS, INFLAMMATION &POST-OP COGNITIVE DYSFUNCTION$427,712
R01 · FY2001 · AG
GENETICS, INFLAMMATION &POST-OP COGNITIVE DYSFUNCTION$403,786
R01 · FY2000 · AG
GENETIC BASIS OF COGNITIVE DECLINE AFTER SUGERY$261,145
R01 · FY2000 · HL
Genetic basis of cognitive decline after surgery$0
M01 · FY2000 · RR
Neuroprotection with lidocaine during cardiac surgery$0
M01 · FY2000 · RR
Neuroprotection with lidocaine during cardiac surgery$0
M01 · FY2000 · RR
Genetic basis of cognitive decline after surgery$0
M01 · FY2000 · RR